Description
|
Name
|
Catalog No.
|
Size
|
|
Recombinant Human C5AR Protein-VLP
|
C230758E
|
20 μg
|
|
C230758S
|
100 μg
|
|
C230758M
|
100 μg
|
|
C230758L
|
1 mg
|
Product Properties
|
Synonyms
|
C5AR / C5AR1 /C5R1
|
|
Source
|
HEK293 Cells
|
|
AA sequence
|
Accession #P21730: Met1 - Val350
|
|
Endotoxin
|
< 1EU per μg by the LAL method.
|
|
Purity
|
>90% as determined by DLS.
|
|
Formulation
|
115mM Gly 4% trehalose
|
|
Activity
|
ELISA：Immobilized Human C5AR VLP at 5 ug/mL (30 uL/well) can bind avdoralimab, The EC50 was approximately 0.008278 ug/ml.
|
|
Applications
|
ELISA, Kinetics (BLI), Kinetics (SPR), Immunization
|
|
Dilution
|
Dilute with PBS.
|
Figure
Figure 1. Immobilized Human C5AR VLP at 5 ug/mL (30 uL/well) can bind avdoralimab, The EC50 was approximately 0.008278 ug/ml.
Storage
The product should be stored at -85~-65℃ for 1 year from date of receipt.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Cautions
1. Please operate with lab coats and disposable gloves,for your safety.
2. This product is for research use only.
